{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T13:07:50Z","timestamp":1781356070286,"version":"3.54.1"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.bioorg.2023.106606","type":"journal-article","created":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T21:15:30Z","timestamp":1683839730000},"page":"106606","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Design, synthesis and evaluation of 2-aryl quinoline derivatives against 12R-lipoxygenase (12R-LOX): Discovery of first inhibitor of 12R-LOX"],"prefix":"10.1016","volume":"138","author":[{"given":"Harshavardhan","family":"Bhuktar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharda","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumar Reddy","family":"Kakularam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srikanth","family":"Battu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manupati","family":"Srikanth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susmita","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghavender","family":"Medishetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Ram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.C.","family":"Jagadish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahaboobkhan","family":"Rasool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandipan","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nooruddin","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pallu","family":"Reddanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas","family":"Oruganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manojit","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2023.106606_b0005","unstructured":"WHO (World Health Organization) global report on psoriasis, Geneva, 2006."},{"issue":"4","key":"10.1016\/j.bioorg.2023.106606_b0010","first-page":"278","article-title":"Diagnosis and management of psoriasis","volume":"63","author":"Kim","year":"2017","journal-title":"Can. Fam. Physician"},{"issue":"6","key":"10.1016\/j.bioorg.2023.106606_b0015","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.3390\/ijms20061475","article-title":"Psoriasis pathogenesis and treatment","volume":"20","author":"Rendon","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2023.106606_b0020","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.880201","article-title":"Epidemiology of psoriasis and comorbid diseases: a narrative review","volume":"13","author":"Bu","year":"2022","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.bioorg.2023.106606_b0025","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/0190-9622(95)91336-X","article-title":"Disease concomitance in psoriasis","volume":"32","author":"Henseler","year":"1995","journal-title":"J. Am. Acad. Dermatol."},{"issue":"6","key":"10.1016\/j.bioorg.2023.106606_b0030","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.clindermatol.2007.08.006","article-title":"Comorbidities in psoriasis","volume":"25","author":"Christophers","year":"2007","journal-title":"Clin. Dermatol."},{"key":"10.1016\/j.bioorg.2023.106606_b0035","unstructured":"Institute for Health Metrics and Evaluation (IHME), Global Burden of Disease Study 2010, Results by Cause 1990\u20132010, Seattle, IHME, 2012."},{"key":"10.1016\/j.bioorg.2023.106606_b0040","doi-asserted-by":"crossref","first-page":"16082","DOI":"10.1038\/nrdp.2016.82","article-title":"Psoriasis","volume":"2","author":"Greb","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"9","key":"10.1016\/j.bioorg.2023.106606_b0045","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1365-4362.1996.tb03687.x","article-title":"Skin disease and socioeconomic conditions in rural Africa: Tanzania","volume":"35","author":"Gibbs","year":"1996","journal-title":"Int. J. Dermatol."},{"issue":"6","key":"10.1016\/j.bioorg.2023.106606_b0050","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1111\/bjd.12230","article-title":"Is the prevalence of psoriasis increasing? A 30\u2013year follow-up of a population\u2013based cohort","volume":"168","author":"Danielsen","year":"2013","journal-title":"Br. J. Dermatol."},{"issue":"9","key":"10.1016\/j.bioorg.2023.106606_b0055","first-page":"504","article-title":"The challenge of managing psoriasis: unmet medical needs and stakeholder perspectives","volume":"9","author":"Feldman","year":"2016","journal-title":"Am. Health Drug Benefits"},{"issue":"1","key":"10.1016\/j.bioorg.2023.106606_b0060","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3109\/09546634.2013.826341","article-title":"Biologic fatigue in psoriasis","volume":"25","author":"Levin","year":"2014","journal-title":"J. Dermatol. Treat."},{"issue":"6","key":"10.1016\/j.bioorg.2023.106606_b0065","doi-asserted-by":"crossref","first-page":"489","DOI":"10.4103\/2229-5178.193915","article-title":"Biologics use in Indian psoriasis patients","volume":"7","author":"Rajagopalan","year":"2016","journal-title":"Indian Dermatol. Online J."},{"issue":"5","key":"10.1016\/j.bioorg.2023.106606_b0070","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/ddr.21263","article-title":"Small Molecules in the Treatment of Psoriasis","volume":"76","author":"Torres","year":"2015","journal-title":"Drug Dev. Res."},{"issue":"3","key":"10.1016\/j.bioorg.2023.106606_b0075","first-page":"390","article-title":"The role of lipoxygenases in epidermis","volume":"1841","author":"Krieg","year":"2014","journal-title":"BBA"},{"issue":"4","key":"10.1016\/j.bioorg.2023.106606_b0080","first-page":"308","article-title":"Mammalian lipoxygenases and their biological relevance","volume":"1851","author":"Kuhn","year":"2015","journal-title":"BBA"},{"key":"10.1016\/j.bioorg.2023.106606_b0085","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.redox.2015.08.006","article-title":"The role of lipoxygenases in pathophysiology; new insights and future perspectives","volume":"6","author":"Mashima","year":"2015","journal-title":"Redox Biol."},{"issue":"12","key":"10.1016\/j.bioorg.2023.106606_b0090","doi-asserted-by":"crossref","first-page":"6744","DOI":"10.1073\/pnas.95.12.6744","article-title":"A, 12R-lipoxygenase in human skin: mechanistic evidence, molecular cloning, and expression","volume":"95","author":"Boeglin","year":"1998","journal-title":"PNAS"},{"issue":"3","key":"10.1016\/j.bioorg.2023.106606_b0095","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0923-1811(99)00042-0","article-title":"Psoriasis and the arachidonic acid cascade","volume":"21","author":"Ikai","year":"1999","journal-title":"J. Dermatol. Sci."},{"issue":"1","key":"10.1016\/j.bioorg.2023.106606_b0100","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1083\/jcb.200612116","article-title":"12R-lipoxygenase deficiency disrupts epidermal barrier function","volume":"177","author":"Epp","year":"2007","journal-title":"J. Cell Biol."},{"issue":"6","key":"10.1016\/j.bioorg.2023.106606_b0105","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/1523-1747.ep12273519","article-title":"Biosynthesis of lipoxygenase products by enzyme preparations from normal and psoriatic skin","volume":"83","author":"Ziboh","year":"1984","journal-title":"J. Invest. Dermatol."},{"issue":"2","key":"10.1016\/j.bioorg.2023.106606_b0110","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/1523-1747.ep12581645","article-title":"Arachidonic acid transformations in normal and psoriatic skin","volume":"73","author":"Hammarstr\u00f6m","year":"1979","journal-title":"J. Invest. Dermatol."},{"issue":"12","key":"10.1016\/j.bioorg.2023.106606_b0115","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.1073\/pnas.72.12.5130","article-title":"Increased concentrations of nonesterified arachidonic acid, 12L-hydroxy-5,8,10,14-eicosatetraenoic acid, prostaglandin E2, and prostaglandin F2\u03b1 in epidermis of psoriasis","volume":"72","author":"Hammarstr\u00f6m","year":"1975","journal-title":"Proc. Nat. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.bioorg.2023.106606_b0120","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0090-6980(83)90178-8","article-title":"The identification of hydroxy fatty acids in psoriatic skin","volume":"26","author":"Camp","year":"1983","journal-title":"Prostaglandins"},{"issue":"9","key":"10.1016\/j.bioorg.2023.106606_b0125","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1073\/pnas.71.9.3400","article-title":"Prostagland endoperoxides. Novel transformations of arachidonic acid in human platelets","volume":"71","author":"Hamberg","year":"1974","journal-title":"Proc. Nat. Acad. Sci. USA"},{"issue":"10","key":"10.1016\/j.bioorg.2023.106606_b0130","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.1073\/pnas.71.10.3824","article-title":"Prostaglandin endoperoxides. A new concept concerning the mode of action and release of prostaglandins","volume":"71","author":"Hamberg","year":"1974","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bioorg.2023.106606_b0135","doi-asserted-by":"crossref","unstructured":"F. Jobard, C. Lef\u00e8vre, A. Karaduman, C. Blanchet-Bardon, S. Emre, J. Weissenbach, M. Ozg\u00fcc, M. Lathrop, J.F. Prud'homme, J. Fischer, Lipoxygenase-3 (ALOXE3) and 12(R)-lipoxygenase (ALOX12B) are mutated in non-bullous congenital ichthyosiform erythroderma (NCIE) linked to chromosome 17p13.1, Hum. Mol. Genet. 11 (1) (2002) 107-113.","DOI":"10.1093\/hmg\/11.1.107"},{"issue":"4","key":"10.1016\/j.bioorg.2023.106606_b0140","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/humu.20236","article-title":"Mutation spectrum and functional analysis of epidermis-type lipoxygenases in patients with autosomal recessive congenital ichthyosis","volume":"26","author":"Eckl","year":"2005","journal-title":"Hum. Mutat."},{"issue":"6","key":"10.1016\/j.bioorg.2023.106606_b0145","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s11926-007-0075-1","article-title":"Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines","volume":"9","author":"Fitch","year":"2007","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.bioorg.2023.106606_b0150","unstructured":"(a) D. Dub\u00e9, M. Blouin, C. Brideau, C. C. Chan, S. Desmarais, D. Ethier, J. P. Falgueyret, R. W. Friesen, M. Girard, Y. Girard, J. Guay, D. Riendeau, P. Tagari, R. N. Young, Quinolines as potent 5-lipoxygenase inhibitors: synthesis and biological profile of L-746,530. Bioorg Med Chem Lett. 8 (1998) 1255-1260; doi: 10.1016\/s0960-894x(98)00201-7. (b) S. Dianat, S. Moghimi, M. Mahdavi, H. Nadri, A. Moradi, L. Firoozpour, S. Emami, A. Mouradzadegun, A. Shafiee, A. Foroumadi, Quinoline-based imidazole-fused heterocycles as new inhibitors of 15-lipoxygenase, J. Enzyme Inhib. Med. Chem. 31 (2016) 205-209, doi: 10.1080\/14756366.2016.1206087; (c) A. M. Ghanim, S. Rezq, T. S. Ibrahim, D. G. Romero, H. Kothayer, Novel 1,2,4-triazine-quinoline hybrids: The privileged scaffolds as potent multi-target inhibitors of LPS-induced inflammatory response via dual COX-2 and 15-LOX inhibition. Eur J Med Chem. 219 (2021) 113457; doi: 10.1016\/j.ejmech.2021.113457; (d) V. Kenyon, G. Rai, A. Jadhav, L. Schultz, M. Armstrong, J.B. Jameson 2nd, S. Perry, N. Joshi, J.M. Bougie, W. Leister, D.A. Taylor-Fishwick, J.L. Nadler, M. Holinstat, A. Simeonov, D.J. Maloney, T.R. Holman, Discovery of potent and selective inhibitors of human platelet-type 12-lipoxygenase, J Med Chem. 54 (15) (2011) 5485-5497."},{"issue":"5113","key":"10.1016\/j.bioorg.2023.106606_b0155","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1126\/science.8502991","article-title":"The three-dimensional structure of an arachidonic acid 15-lipoxygenase","volume":"260","author":"Boyington","year":"1993","journal-title":"Science"},{"issue":"26","key":"10.1016\/j.bioorg.2023.106606_b0160","doi-asserted-by":"crossref","first-page":"22377","DOI":"10.1074\/jbc.M112.343285","article-title":"Structure of a calcium-dependent 11R-lipoxygenase suggests a mechanism for Ca2+ regulation","volume":"287","author":"Eek","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2023.106606_b0165","doi-asserted-by":"crossref","first-page":"4811","DOI":"10.1096\/fj.13-235952","article-title":"Structure and interaction with phospholipids of a prokaryotic lipoxygenase from Pseudomonas aeruginosa","volume":"27","author":"Garreta","year":"2013","journal-title":"FASEB J."},{"issue":"6014","key":"10.1016\/j.bioorg.2023.106606_b0170","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1126\/science.1197203","article-title":"The structure of human 5-lipoxygenase","volume":"331","author":"Gilbert","year":"2011","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.bioorg.2023.106606_b0175","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/nsb1297-1003","article-title":"The structure of mammalian 15-lipoxygenase reveals similarity to the lipases and the determinants of substrate specificity","volume":"4","author":"Gillmor","year":"1997","journal-title":"Nat. Struct. Biol."},{"issue":"47","key":"10.1016\/j.bioorg.2023.106606_b0180","doi-asserted-by":"crossref","first-page":"39545","DOI":"10.1074\/jbc.M506675200","article-title":"Insights from the X-ray crystal structure of coral 8R-lipoxygenase: calcium activation via a C2-like domain and a structural basis of product chirality","volume":"280","author":"Oldham","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2023.106606_b0185","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.str.2012.06.003","article-title":"Crystal structure of 12-lipoxygenase catalytic-domain-inhibitor complex identifies a substrate-binding channel for catalysis","volume":"20","author":"Xu","year":"2012","journal-title":"Structure"},{"issue":"46","key":"10.1016\/j.bioorg.2023.106606_b0190","doi-asserted-by":"crossref","first-page":"31905","DOI":"10.1074\/jbc.M114.599662","article-title":"Crystal structure of a lipoxygenase in complex with substrate","volume":"289","author":"Neau","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2023.106606_b0195","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/pro.2626","article-title":"The structural basis for specificity in lipoxygenase catalysis","volume":"24","author":"Newcomer","year":"2015","journal-title":"Protein Sci."},{"issue":"1","key":"10.1016\/j.bioorg.2023.106606_b0200","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bbrc.2005.07.185","article-title":"A comprehensive model of positional and stereo control in lipoxygenases","volume":"338","author":"Coffa","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"12","key":"10.1016\/j.bioorg.2023.106606_b0205","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.1016\/j.bmc.2006.01.057","article-title":"Baicalein is a potent in vitro inhibitor against both reticulocyte 15-human and platelet 12-human lipoxygenases","volume":"14","author":"Deschamps","year":"2006","journal-title":"Bioorg. Med. Chem."},{"issue":"7\u20138","key":"10.1016\/j.bioorg.2023.106606_b0210","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.drudis.2012.11.003","article-title":"Quinolines: a new hope against inflammation","volume":"18","author":"Mukherjee","year":"2013","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioorg.2023.106606_b0215","unstructured":"(a) P. Reddanna, K. K. Reddy, N. Khan, H. D. Bhuktar, S. Shukla, M. Pal, Heterocyclic compounds as lipoxygenase inhibitors. World Patent Application WO 2020\/255156 A1, 24 Dec 2020; Indian patent granted with number 377565 on 22\/9\/2021; (b) Lipoxygenase inhibitors to treat psoriasis and other skin disorders\u201d \u2013 patent granted to University of Hyderabad and Dr. Reddy\u2019s Institute of Life Sciences: https:\/\/herald.uohyd.ac.in\/lipoxygenase-inhibitors-to-treat-psoriasis-and-other-skin-disorders-patent-granted-to-university-of-hyderabad-and-dr-reddys-institute-of-life-sciences\/."},{"key":"10.1016\/j.bioorg.2023.106606_b0220","doi-asserted-by":"crossref","unstructured":"(a) P. Aparoy, T. Leela, R.N. Reddy, P. Reddanna, Computational analysis of R and S isoforms of 12-Lipoxygenases: Homology modelling and docking studies, Journal of Molecular Graphics and Modelling 27 (6) (2009) 744\u2013750. (b) D. Sun, M. McDonnell, X.S. Chen, M.M. Lakkis, H. Li, S.N. Isaacs, S.H. Elsea, P.I. Patel, C.D. Funk Human, 12(R)-lipoxygenase and the mouse ortholog. Molecular cloning, expression, and gene chromosomal assignment, J Biol Chem. 273 (50) (1998) 33540-33547.","DOI":"10.1016\/j.jmgm.2008.11.009"},{"issue":"44","key":"10.1016\/j.bioorg.2023.106606_b0225","doi-asserted-by":"crossref","first-page":"36633","DOI":"10.1074\/jbc.M508260200","article-title":"Sequence determinants for the reaction specificity of murine (12R)-lipoxygenase","volume":"280","author":"Meruvu","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"31","key":"10.1016\/j.bioorg.2023.106606_b0230","doi-asserted-by":"crossref","first-page":"6513","DOI":"10.1016\/j.tet.2004.06.005","article-title":"Synthesis, experimental and theoretical NMR study of 2\u2032-hydroxychalcones bearing a nitro substituent on their B ring","volume":"60","author":"Barros","year":"2004","journal-title":"Tetrahedron"},{"issue":"10","key":"10.1016\/j.bioorg.2023.106606_b0235","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1016\/j.bmc.2011.04.010","article-title":"Synthesis and antifungal activities of natural and synthetic bioflavonoids","volume":"19","author":"Sagrera","year":"2011","journal-title":"Bioorg. Med. Chem."},{"issue":"31","key":"10.1016\/j.bioorg.2023.106606_b0240","doi-asserted-by":"crossref","first-page":"5893","DOI":"10.1016\/S0040-4039(03)01374-1","article-title":"One-pot synthesis of 2-(2-hydroxyaryl)quinolines: reductive coupling reactions of 2\u2032-hydroxy-2-nitrochalcones","volume":"44","author":"Barros","year":"2003","journal-title":"Tetrahedron Lett."},{"issue":"6","key":"10.1016\/j.bioorg.2023.106606_b0245","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1002\/jhet.485","article-title":"Chemoselective synthesis of quinoline N-oxides from 3-(2-nitrophenyl)-3-hydroxypropanones","volume":"47","author":"Okuma","year":"2010","journal-title":"J. Heterocycl. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2023.106606_b0250","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1021\/jacs.1c11092","article-title":"Enantioselective dearomative [3 + 2] umpolung annulation of n-heteroarenes with alkynes","volume":"144","author":"Yang","year":"2022","journal-title":"J. Am. Chem. Soc."},{"issue":"5","key":"10.1016\/j.bioorg.2023.106606_b0255","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.bmc.2012.01.012","article-title":"AlCl3 induced (hetero)arylation of 2,3-dichloroquinoxaline: A one-pot synthesis of mono\/disubstituted quinoxalines as potential antitubercular agents","volume":"20","author":"Kumar","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106606_b0260","doi-asserted-by":"crossref","first-page":"112434","DOI":"10.1016\/j.biopha.2021.112434","article-title":"Paralog- and ortholog-specificity of inhibitors of human and mouse lipoxygenase-isoforms","volume":"145","author":"Kakularam","year":"2022","journal-title":"Biomed. Pharmacotherapy"},{"key":"10.1016\/j.bioorg.2023.106606_h0265","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bbacli.2016.06.002","article-title":"Induction of differentiation in psoriatic keratinocytes by propylthiouracil and fructose","volume":"6","author":"Arul","year":"2016","journal-title":"BBA Clin."},{"key":"10.1016\/j.bioorg.2023.106606_h0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108795","article-title":"3, 3'- diindolylmethane hinders IL-17A\/IL-17RA interaction and mitigates imiquimod-induced psoriasiform in mice","volume":"109","author":"Srikanth","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.bioorg.2023.106606_b0270","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9","article-title":"The Ki-67 protein: from the known and the unknown","volume":"182","author":"Scholzen","year":"2000","journal-title":"J. Cell. Physiol."},{"issue":"3","key":"10.1016\/j.bioorg.2023.106606_b0275","doi-asserted-by":"crossref","first-page":"7","DOI":"10.5826\/dpc.0503a02","article-title":"Diagnostic utility of Ki-67 and Cyclin D1 immunostaining in differentiation of psoriasis vs. other psoriasiform dermatitis","volume":"5","author":"Sezer","year":"2015","journal-title":"Dermatol Pract Concept."},{"issue":"4","key":"10.1016\/j.bioorg.2023.106606_b0280","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1051\/bmdcn\/2019090426","article-title":"Immunohistochemical expression of P53, Ki-67, and CD34 in psoriasis and psoriasiform dermatitis","volume":"9","author":"Ramezani","year":"2019","journal-title":"Biomedicine (Taipei)"},{"issue":"33","key":"10.1016\/j.bioorg.2023.106606_b0285","doi-asserted-by":"crossref","first-page":"E3422","DOI":"10.1073\/pnas.1400513111","article-title":"IL-17 drives psoriatic inflammation via distinct, target cell-specific mechanisms","volume":"111","author":"Ha","year":"2014","journal-title":"PNAS"},{"issue":"5","key":"10.1016\/j.bioorg.2023.106606_b0290","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1155\/MI.2005.273","article-title":"Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity","volume":"2005","author":"Arican","year":"2005","journal-title":"Mediators Inflamm."},{"issue":"32","key":"10.1016\/j.bioorg.2023.106606_b0295","doi-asserted-by":"crossref","first-page":"10297","DOI":"10.1021\/bi020320q","article-title":"Kinetics of inhibition of leukocyte 12-lipoxygenase by the isoform-specific inhibitor 4-(2-oxapentadeca-4-yne)phenylpropanoic acid","volume":"41","author":"Moody","year":"2002","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.bioorg.2023.106606_b0300","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0006-291X(88)90599-2","article-title":"Soybean lipoxygenase-catalyzed oxidations by linoleic acid hydroperoxide: different reducing substrates and dehydrogenation of phenidone and BW 755C","volume":"151","author":"Mansuy","year":"1988","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.bioorg.2023.106606_b0305","first-page":"85","article-title":"Lipoxygenase inhibitory activity of 6-pentadecanylsalicylic acid without prooxidant effect","volume":"5","author":"Kubo","year":"2010","journal-title":"Nat. Prod. Commun."},{"issue":"4","key":"10.1016\/j.bioorg.2023.106606_b0310","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/0006-2952(93)90185-Y","article-title":"Criteria for the identification of non-redox inhibitors of 5-lipoxygenase","volume":"45","author":"Falgueyret","year":"1993","journal-title":"Biochem. Pharmacol."},{"issue":"20","key":"10.1016\/j.bioorg.2023.106606_b0315","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1021\/jm960301c","article-title":"Dioxabicyclooctanyl naphthalenenitriles as nonredox 5-lipoxygenase inhibitors: structure-activity relationship study directed toward the improvement of metabolic stability","volume":"39","author":"Delorme","year":"1996","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106606_b0320","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"key":"10.1016\/j.bioorg.2023.106606_h0330","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1021\/ct300400x","article-title":"Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone phi, psi and side-chain chi1 and chi2 dihedral angles","volume":"8","author":"Best","year":"2012","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.bioorg.2023.106606_h0335","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nmeth.4067","article-title":"CHARMM36m: an improved force field for folded and intrinsically disordered proteins","volume":"14","author":"Huang","year":"2016","journal-title":"Nat. Methods"},{"issue":"2","key":"10.1016\/j.bioorg.2023.106606_b0330","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.bioorg.2023.106606_b0335","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"Swiss ADME: a free web tool to evaluate pharmacokinetics, druglikeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"issue":"7519","key":"10.1016\/j.bioorg.2023.106606_b0340","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/513481a","article-title":"Chemistry: chemical con artists foil drug discovery","volume":"513","author":"Baell","year":"2014","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.bioorg.2023.106606_b0345","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206823002675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206823002675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:47:50Z","timestamp":1758617270000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206823002675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":71,"alternative-id":["S0045206823002675"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2023.106606","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and evaluation of 2-aryl quinoline derivatives against 12R-lipoxygenase (12R-LOX): Discovery of first inhibitor of 12R-LOX","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2023.106606","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106606"}}